Louis Garguilo interviews Massimo Dominici, a professional of eminent status in the CGT field and founder of Rigenerand, about CDMOs. Over the years, Dominici and Mari …

Technologies that gather and store health-related data are generating real-world data (RWD) and real-world evidence (RWE) that are increasingly being applied in healthcare decision-making. As …

A great many new and varied approaches to clinical trial management are being adopted during the COVID-19 pandemic through the help of virtualisation tools, strong …

The Fundamental Aspects of Creating an Agile, Scalable and Flexible Solution Capable of Delivering Better Results than Previous Study Models Bogged down by recruiting challenges …

When the health authorities began placing further emphasis on medicinal product data standards, the overlap between regulatory operations and systems beyond the regulatory scope became …

Clinical trials themselves have their own complications. Regulatory compliance and safety reporting are of the utmost importance in managing clinical trials. When you add to …

According to the largest analysis of almost 7,500 clinical and regulatory phase transitions, the likelihood of an oncology drug progressing from Phase I clinical testing …

The market for Advanced Therapies has come a long way in the last decade, to the point that some cell and gene therapies have already …

Data quality concerns are frequent in schizophrenia clinical trials, causing many to suffer from drug placebo separation. Machine learning offers the opportunity to proactively identify …

Machine Learning (ML) and Artificial Intelligence (AI) have come to the forefront of data analytics with the promise of generating new medical insights. However, for …